RiteMED Carbamazepine Adverse Reactions

The most frequent adverse reactions reported, particularly during the initial phase of therapy, are drowsiness, dizziness, unsteadiness on the feet, nausea and vomiting, as well as allergic skin reactions. These reactions can be minimized by initiating treatment at a low dosage.
The more severe adverse reactions observed are the skin, hepatic, cardiovascular and hematologic reactions, which require discontinuation of therapy.
The following additional adverse reactions have been reported: Skin: Lyell's syndrome, Stevens-Johnson syndrome, urticaria, photosensitivity reactions, exfoliative dermatitis.
Hematologic: Leukopenia, agranulocytosis, aplastic anemia, thrombocytopenia, leukocytosis, acute intermittent porphyria.
Cardiovascular: Hypertension or hypotension, arrhythmias, bradycardia, congestive heart failure aggravation of coronary artery disease.
Respiratory: Pulmonary hypersensitivity characterized by fever, dyspnea, pneumonitis or pneumonia.
Gastrointestinal: Nausea, vomiting, diarrhea, constipation, anorexia, glossitis, stomatitis.
Musculoskeletal: Muscle pain or cramp, arthralgia.